NICFF yields 5.30% · MRK yields 2.81%● Live data
📍 NICFF pulled ahead of the other in Year 1
Combined, NICFF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NICFF + MRK for your $10,000?
Nichias Corporation manufactures and sells thermal insulation materials primarily in Japan. It operates in five segments: Energy and Industrial Plants, Industrial Products, Advanced Products, Autoparts, and Building Materials. The company offers gaskets and packings, including non-asbestos gaskets and packings, rubber type gaskets, other seal products, and peripheral function materials; and thermal insulation materials, such as fiber products, high performance thermal insulation materials, heat-insulation boards, and cryogenic insulation materials, as well as thermal insulation materials for molten aluminum. It also provides various fluoropolymer materials, processed products, and corrosion-resistant linings, as well as tubes, hoses, and bellows; filter products and environmental equipment; and auto parts comprising sealing materials, retaining parts/materials, and sound-proofing parts/materials, as well as heat-protection products, control parts, and materials. In addition, the company offers building materials for buildings and housing; and undertakes hot and cold insulation, refractory, electric heater tracing, acoustic insulation, and aerogel heat-insulation works. Further, it provides furniture sliding pads, and friction and agricultural materials. The company serves electric power and gas; waste incineration plants; chemical, petroleum refinery, and petrochemical; steel and non-ferrous metals; aluminum casting and processing; paper; building and housing construction; semiconductor and flat panel display; foods and pharmaceutical; medical equipment; electric equipment; aerospace; automobiles; ship building, maintenance, and repair; industrial equipment; and others industries. Nichias Corporation was incorporated in 1896 and is headquartered in Tokyo, Japan.
Full NICFF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.